Evidence map›Paper›PMID 27932544›Full record

ArticleGenetics2017

Improving the Identification of Phenotypic Abnormalities and Sexual Dimorphism in Mice When Studying Rare Event Categorical Characteristics.

Natasha A Karp, Ruth Heller, Shay Yaacoby, Jacqueline K White, Yoav Benjamini

Abstract read
In one paragraph

Article in Genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Inefficient development of syncytiotrophoblasts in theProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natasha A KarpMouse Informatics Group, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, United Kingdom natasha.karp@astrazeneca.com.ORCID 0000-0002-8404-2907
Ruth HellerDepartment of Statistics and Operations Research, School of Mathematical Sciences, Tel Aviv University, Israel.
Shay YaacobyDepartment of Statistics and Operations Research, School of Mathematical Sciences, Tel Aviv University, Israel.
Jacqueline K WhiteMouse Genetics Project, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, United Kingdom.
Yoav BenjaminiDepartment of Statistics and Operations Research, School of Mathematical Sciences, Tel Aviv University, Israel.

Funding

Mouse Phenotyping Informatics Infrastruture - MP12U54HG006370 · NHGRI · EUROPEAN MOLECULAR BIOLOGY LABORATORY · PI BROWN, STEVE, FLICEK, PAUL · 2011 to 2015
$11.4M
European Research Council 294519NHGRI NIH HHS U54 HG006370Wellcome Trust WT098051
6 · The paper itself

Abstract

Biological research frequently involves the study of phenotyping data. Many of these studies focus on rare event categorical data, and functional genomics studies typically study the presence or absence of an abnormal phenotype. With the growing interest in the role of sex, there is a need to assess the phenotype for sexual dimorphism. The identification of abnormal phenotypes for downstream research is challenged by the small sample size, the rare event nature, and the multiple testing problem, as many variables are monitored simultaneously. Here, we develop a statistical pipeline to assess statistical and biological significance while managing the multiple testing problem. We propose a two-step pipeline to initially assess for a treatment effect, in our case example genotype, and then test for an interaction with sex. We compare multiple statistical methods and use simulations to investigate the control of the type-one error rate and power. To maximize the power while addressing the multiple testing issue, we implement filters to remove data sets where the hypotheses to be tested cannot achieve significance. A motivating case study utilizing a large scale high-throughput mouse phenotyping data set from the Wellcome Trust Sanger Institute Mouse Genetics Project, where the treatment is a gene ablation, demonstrates the benefits of the new pipeline on the downstream biological calls.

Indexed as

Models, GeneticPhenotypeSex CharacteristicsAnimalsFemaleGenotypeMaleMiceProbabilitygene–phenotype mapmouse modelsmultiple testingrare eventssexual dimorphism

Identifiers

PMID27932544
PMCPMC5289831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.